philanthropy.org | 990 Resource | FAQ Verify yourself Sign in
DM
Person · officer / director

Dr Melvin Spigelman

President/CEO · Global Alliance for Tb Drug Development INC

President/CEO at Global Alliance for Tb Drug Development INC. Listed as an officer, director, or key employee across 1 organization on the Form 990 record.

This is me
Organizations
1
Roles reported
1
Reported compensation
$940K

Who this is

Profile

Everything on the left is verified from the IRS filings. The biography on the right is compiled from public web sources and grounded to that filed record.

✓ Verified from filings
●
Reported as President/CEO of Global Alliance for Tb Drug Development INC, based in New York, NY.
●
Received $940K in total reported compensation on the most recent Form 990 (Part VII).
Facts extracted directly from each organization's Form 990, Part VII.
Biography Web-sourced

President and CEO of the Global Alliance for TB Drug Development (TB Alliance) since 2009. Pioneer of regimen-based TB drug development paradigm; leads international TB drug discovery and development efforts.

Compiled from public web sources (4 cited), grounded to the filed record.

Track record

Career & tenure

Real tenure, career, and education — from public web sources, what you need to vet a founder or leader beyond the filing window.

Tenure here
CEO since 2009

Verify independently

Find them online

Primary links to check this person directly — their own pages, not an aggregator.

Affiliations

Organizations

Global Alliance for Tb Drug Development INC President/CEO · $63.7M revenue · New York, NYTO ACCELERATE THE DISCOVERY & DEVELOPMENT OF NEW DRUGS TO FACILITATE THE CONTROL OF TUBERCULOSIS THROUGHOUT THE WORLD AND THE ACCESSIBILITY OF THESE…pay $964K → $940KFiled FY2024, FY2023, FY2022, FY2021, FY2020 · Source: Form 990, Part VII
$940Kreported comp

Network

Serves alongside

Other officers, directors & key employees at this person's organizations, by latest reported compensation.

D
Sr. VP, Research & Development · FY2024
$581K
D
Sr. VP, Chief Scientific Officer · FY2024
$565K
M
VP, Chief Medical Officer · FY2024
$498K
D
Sr. Medical Officer & VP · FY2020
$489K
C
Secretary/CAO · FY2024
$470K
R
Sr. VP, Business Development · FY2024
$449K
K
Sr. VP, Program & Alliance Management · FY2024
$432K
S
Sr. Director, Medical Affairs · FY2024
$430K
A
Treasurer/CFO · FY2024
$422K
S
Sr. VP, Market Access · FY2024
$418K
D
Sr. Medical Officer · FY2022
$394K
W
Senior VP, External Affairs · FY2020
$382K

Network

Recommendations

Written by other verified members of the network — visible once you're a verified person yourself.

Loading…

Explore

Similar organizations

Nonprofits working in the same field — explore who else operates in this space.

Parkinsons Foundation INC$84.2M revenue · New York, NY
Punch 4 Parkinsons Corporation$22.1M revenue · Walpole, MA
Access to Advanced Health Institute$18.4M revenue · Seattle, WA
Als Therapy Development Foundation INC$16.1M revenue · Watertown, MA
Hae International$6.6M revenue · Fairfax, VA

People like this

Similar leaders

Leaders at organizations in the same field, by reported compensation.

C
Former CEO · Sanford Burnham Prebys Medical Discovery Institute
$5.0M
L
Trustee, President, and CEO · Dana-Farber Cancer Institute
$3.7M
D
VP & Chief Investment Officer · Howard Hughes Medical Institute
$3.6M
D
CEO (thru 12/31/2022) · Transcelerate Biopharma INC
$2.6M
K
President · Sanford Burnham Prebys Medical Discovery Institute
$2.6M
L
President & CEO · Jackson Laboratory
$2.5M
Public data from IRS Form 990 e-file & the Business Master File. Individuals appear here because they were named as an officer, director, or key employee on a nonprofit's Form 990; people are grouped by name plus corroborating evidence (Schedule R, shared address, shared board members). · philanthropy.org